Omnicell Technologies (OMCL) Stock Rating Upgraded by BidaskClub

Omnicell Technologies (NASDAQ:OMCL) was upgraded by research analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued on Saturday.

A number of other equities analysts have also weighed in on the stock. Cantor Fitzgerald reiterated a “buy” rating and issued a $63.00 price target on shares of Omnicell Technologies in a research report on Tuesday, April 3rd. Zacks Investment Research upgraded shares of Omnicell Technologies from a “sell” rating to a “hold” rating in a research report on Friday, February 2nd. Piper Jaffray upped their price target on shares of Omnicell Technologies from $38.00 to $44.00 and gave the stock a “neutral” rating in a research report on Friday, February 2nd. Craig Hallum lowered shares of Omnicell Technologies from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Finally, Oppenheimer reiterated a “buy” rating and issued a $55.00 price target on shares of Omnicell Technologies in a research report on Monday, January 29th. Five equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $56.14.

How to Become a New Pot Stock Millionaire

Shares of NASDAQ OMCL opened at $43.95 on Friday. The company has a market cap of $1,707.81, a P/E ratio of 244.17, a price-to-earnings-growth ratio of 3.62 and a beta of 0.74. Omnicell Technologies has a 12-month low of $38.00 and a 12-month high of $55.40. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.73 and a quick ratio of 1.28.

Omnicell Technologies (NASDAQ:OMCL) last posted its quarterly earnings results on Thursday, February 1st. The company reported $0.54 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.02. The business had revenue of $198.26 million during the quarter, compared to analyst estimates of $205.50 million. Omnicell Technologies had a net margin of 2.88% and a return on equity of 1.54%. The company’s revenue was up 13.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.37 earnings per share. equities research analysts anticipate that Omnicell Technologies will post 0.77 EPS for the current year.

In related news, Director Gary S. Petersmeyer sold 575 shares of the company’s stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $44.43, for a total transaction of $25,547.25. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Chairman Randall A. Lipps sold 8,186 shares of the company’s stock in a transaction on Tuesday, March 6th. The stock was sold at an average price of $44.21, for a total transaction of $361,903.06. Following the transaction, the chairman now owns 224,206 shares of the company’s stock, valued at approximately $9,912,147.26. The disclosure for this sale can be found here. 3.77% of the stock is currently owned by corporate insiders.

Several large investors have recently modified their holdings of OMCL. California Public Employees Retirement System raised its stake in Omnicell Technologies by 1.6% during the fourth quarter. California Public Employees Retirement System now owns 87,628 shares of the company’s stock valued at $4,250,000 after purchasing an additional 1,388 shares in the last quarter. Conestoga Capital Advisors LLC raised its stake in Omnicell Technologies by 10.8% during the fourth quarter. Conestoga Capital Advisors LLC now owns 1,792,313 shares of the company’s stock valued at $86,927,000 after purchasing an additional 174,607 shares in the last quarter. Kennedy Capital Management Inc. raised its stake in Omnicell Technologies by 199.2% during the fourth quarter. Kennedy Capital Management Inc. now owns 465,483 shares of the company’s stock valued at $22,576,000 after purchasing an additional 309,913 shares in the last quarter. Swiss National Bank raised its stake in Omnicell Technologies by 2.6% during the fourth quarter. Swiss National Bank now owns 63,800 shares of the company’s stock valued at $3,094,000 after purchasing an additional 1,600 shares in the last quarter. Finally, Rhumbline Advisers raised its stake in Omnicell Technologies by 16.6% during the fourth quarter. Rhumbline Advisers now owns 88,153 shares of the company’s stock valued at $4,275,000 after purchasing an additional 12,543 shares in the last quarter.

ILLEGAL ACTIVITY NOTICE: “Omnicell Technologies (OMCL) Stock Rating Upgraded by BidaskClub” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this piece can be viewed at https://www.dispatchtribunal.com/2018/04/09/omnicell-technologies-omcl-stock-rating-upgraded-by-bidaskclub.html.

About Omnicell Technologies

Omnicell, Inc provides automation and business analytics software solutions for medication and supply management in healthcare worldwide. The company operates through two segments, Automation and Analytics, and Medication Adherence. It offers Omnicell Automated Dispensing Cabinets, a dispensing system, which automates the management and dispensing of medications; SinglePointe, a software product that controls medications; AnywhereRN, a software which remotely queue medications from automated dispensing cabinets; Omnicell Analytics and Pandora Analytics reporting and data analytics tools; and Anesthesia Workstation that manages anesthesia supplies and medications.

Analyst Recommendations for Omnicell Technologies (NASDAQ:OMCL)

Receive News & Ratings for Omnicell Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply